$GOVX Up 117% Premarket! 🚀 🔹 GeoVax is a clinical-stage biotech developing vaccines and immunotherapies for infectious diseases and cancer 🔹 Big focus on GEO

$GOVX Up 117% Premarket! 🚀 🔹 GeoVax is a clinical-stage biotech developing vaccines and immunotherapies for infectious diseases and cancer 🔹 Big focus on GEO-MVA, its MVA-based vaccine candidate targeting mpox and smallpox 🧬 🔹 Recent catalyst: GeoVax initiated Phase 3 execution activities under…